SEMAGLUTIDE

PRANA — Semaglutide | Research Use Only

Semaglutide is a GLP-1 receptor agonist peptide currently being studied in preclinical and clinical research for its role in glucoregulatory signaling, insulin secretion pathways, and metabolic function.

Research Areas:

• GLP-1 receptor agonism signaling
• Insulin secretion and glucose regulation
• Metabolic pathway modulation research
• Appetite and energy homeostasis studies

⚠️ Intended Use: Laboratory Research and Analytical Purposes Only
Not for Human or Veterinary Use. This material is not intended for human consumption, injection, administration, diagnosis, treatment, cure, mitigation, or prevention of any disease or medical condition. These statements have not been evaluated by the Food and Drug Administration.